Well if personalized medicine is what counts, then everyone should listen to the description of how Tovaxin is manufactured, personal to the patient, and altered as needed on an annual basis.
Also the discussion and Q+A on the partnering process has me convinced that the talks are real, even if a deal is not imminent.